课题基金 / 基金详情

FACS VANTAGE SE CELL SORTER/FLOW CYTOMETER

FACS VANTAGE SE CELL SORTER/FLOW CYTOMETER
FACS Vantage SE 细胞分选仪/流式细胞仪
批准号:
6053811
负责人:
Hildegard M. Schuller
金额:
$15.0万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-04-01 至 2001-03-31

项目摘要

项目成果

Hildegard M. Schuller的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is an application for a shared instrumentation grant under PAR-99- 031 seeking funds in the amount of $295,649 for the purchase of a state of the art cell sorter/flow cytometer to replace a 14 year old and defunct flow cytometer. This instrument will be housed in a fully equipped core facility located in the College of Veterinary Medicine, University of Tennessee Knoxville. This instrument is needed to support the research of 3 NIH funded investigators at the College of Veterinary Medicine, University of Tennessee Knoxville (Drs. Rouse, Schuller, and Wang) and 1 NIH funded collaborator from the Medical Center University of Tennessee, Knoxville (Dr. Wimalasena). The currently active and pending grants of these investigators depend heavily on the availability of this instrument. The attached quotation from Becton Dickinson is for a FACS Vantage TM/SE Cell Sorter with Argon UV laser, helium-neon laser, pulse processor, fluorescence detection, third laser mount, and INDO- 1 filter- set. If an award is made, other vendors will be given the opportunity to bid against Becton Dickinson. A long-term financial plan facility director, technical facility manager, and advisory committee are described.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The GABA-B receptor is a novel drug target for pancreatic cancer
  • 批准号:
    8064258
  • 项目类别:
  • 资助金额:
    $26.45万
  • 财政年份:
    2009
  • 负责人:
    Hildegard M. Schuller
  • 依托单位:
Modulation of cancer prevention by social stress
  • 批准号:
    7809021
  • 项目类别:
  • 资助金额:
    $50.0万
  • 财政年份:
    2009
  • 负责人:
    Hildegard M. Schuller
  • 依托单位:
The GABA-B receptor is a novel drug target for pancreatic cancer
  • 批准号:
    8252196
  • 项目类别:
  • 资助金额:
    $26.45万
  • 财政年份:
    2009
  • 负责人:
    Hildegard M. Schuller
  • 依托单位:
The GABA-B receptor is a novel drug target for pancreatic cancer
  • 批准号:
    7714157
  • 项目类别:
  • 资助金额:
    $27.27万
  • 财政年份:
    2009
  • 负责人:
    Hildegard M. Schuller
  • 依托单位:
海外基金